Navigation Links
BrainCells Inc. Completes $30 Million Initial Closing of Series B Financing
Date:3/10/2008

MedImmune's William Bertrand, Jr., J.D., joins BrainCells' Board of

Directors

SAN DIEGO, March 10 /PRNewswire/ -- BrainCells Inc. (BCI), a biopharmaceutical company utilizing its platform technology to identify and develop compounds that promote the growth of new neurons for the treatment of central nervous system (CNS) diseases, announced today that it has completed a $30 million initial closing of its Series B financing. New investor MedImmune Ventures joined previous investors Bay City Capital, Oxford Bioscience Partners, Technology Partners, Pappas Ventures and Neuro Ventures in the round. The financing will be used to continue clinical development of BCI's product candidates including BCI-540, and to identify additional assets to further expand its pipeline.

As a part of the Series B financing, BCI also announced the addition of William Bertrand, Jr., J.D., senior vice president and general counsel of MedImmune, to its Board of Directors. Prior to joining MedImmune in 2001 as vice president of legal affairs, Bertrand served in various legal positions at Pharmacia Corporation. He was also general counsel for a life insurance company, a partner at Dickinson, Wright, Moon, Van Dusen & Freeman, and has taught courses at various institutions including the Seton Hall University School of Law.

"The strong interest in this round by our existing investors as well as a new, high-quality investor such as MedImmune Ventures validates the progress the company has made in the area of neurogenesis," said Jim Schoeneck, CEO of BCI. "We are delighted to have MedImmune Ventures join and for Bill to now be a member of our board, bringing his legal expertise and more than a decade of experience in the biotechnology and pharmaceutical industries."

"BCI's application of groundbreaking science in neurogenesis to the treatment of mood disorders and other neurological conditions has the potential to provide a novel t
'/>"/>

SOURCE BrainCells Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. PharmAthene Completes Pharmacokinetic Studies of Protexia(R); Program on Target for IND Filing in 2008
2. D-Pharm Completes Pre-IND Meeting With the FDA for Treatment of Acute Stroke With DP-b99
3. Plurality Completes R&D of its HAL-256 Multicore Processor
4. Cadence Pharmaceuticals Completes $49.3 Million Registered Direct Offering
5. Inverness Medical Innovations Completes Acquisition of BBI Holdings Plc
6. Alynx, Co. Completes Merger With Medical Device Company MiMedx, Inc.
7. Cardium Completes $5.3 Million Registered Direct Offering
8. WuXi PharmaTech Completes Acquisition of AppTec
9. Max Nutrition, Inc. Completes Share Exchange with American Spring Pharmaceutical, Inc.
10. Healionics Corporation Completes Series A Financing
11. ActivBiotics Completes Sale of Fixed Assets; Expands Due Diligence Initiative for the Sale of Intellectual Property, Including Drug Product Candidates

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Calif., Nov. 24 Two more prestigi...e nation,s leading online job board and careers si...ern and Columbia University are now members of the...aining Institutions. ,, The job board, www.bio...he life sciences. While there are hundreds of life...
(Date:11/24/2009)...Health care employment grew by 29,000 jobs in Oct...onsistent growth during the U.S. recession. Howeve...le, and health systems are coming closer to having...t administrators. , (Vocu...tinued growing in October despite the shedding of ...
(Date:11/24/2009)...AI, Nov. 24 /PRNewswire-Asia/ -- Shanghai Biolaxy ...stration (SFDA) has approved the,investigational n...ject,(Nodlin), an innovative insulin formulation t... to initiate its first phase I clinical study. ,...igh blood glucose and poor,metabolism. The complic...
(Date:11/24/2009)...TL , TORONTO, Nov. 24 /PRNewswire-FirstCall/ ...tto Capital Inc., a leading provider of advanced l...earch and fertility clinic markets, today reported...uarter ended September 30, 2009. , , Q3 2009 H...red with $1.43 million in Q3 2008, - Gross pr...
Breaking Biology Technology:Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10
...gs Appear in Sept. 9 Issue of the Journal Nature M... hits with,devastating effects in people with norm...ng others who smoke, or have multiple risk factors...e person suffers a heart attack,and yet another do...esearch Institute have,discovered a mechanism that...
..., Mass., Sept. 10 A free white paper detailing,st...ompliance with federal,state, and local environmen... download at: http://www.eheinc.com/pitfalls.htm ...nd Safety Compliance in,Biotech Companies: Common ...on an analysis of numerous program audits, and off...
... HILLS, Ill. and DUBLIN, Ireland, Sept. 10 /PRNews... of Trintech (Nasdaq: TTPA ), today,announced the...ww.concuity.com . The new website markedly improve...ion about Concuity,s products and,services, and pr...l,professionals in the healthcare industry seeking...
Other Biology Technology:Cleveland Clinic-Led Research Uncovers New Mechanism That Heightens Risk of Heart Disease 2Cleveland Clinic-Led Research Uncovers New Mechanism That Heightens Risk of Heart Disease 3New White Paper Details Strategies for Biotechnology Companies to Improve EH&S Compliance 2Concuity Announces the Launch of Its New Fully Accessible Website - Concuity.Com 2Concuity Announces the Launch of Its New Fully Accessible Website - Concuity.Com 3
(Date:11/26/2009)...ight European countries has shown that closing sch...c could have a significant role in reducing illnes...cess journal BMC Infectious Diseases compared op...nds/holidays, finding that they were reduced when ...Antwerp University, Belgium, led a team of Europea...
(Date:11/26/2009)...nt Staphylococcus Aureus ) and other drug-resista...ture plasma prototype devices have been developed ...dal cocktails. , Two prototype devices have been...thy skin (e.g. hands and feet) in hospitals and pu...t; and another to shoot bacteria-killing agents in...
(Date:11/25/2009)...,t have easy lives. In addition to mammalian immun... enemies called bacteriophages, viruses that kill ...ill, bacteria and another class of microorganisms ...nments such as deep-sea volcanic vents) manage jus...lt-in defense system that helps protect them from ...
Breaking Biology News(10 mins):School closure could reduce swine flu transmission by 21 percent 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Researchers discover biological basis of 'bacterial immune system' 2Researchers discover biological basis of 'bacterial immune system' 3TransUnion Survey Finds Patients Want More Transparency in Hospital Bills and Knowledge of Charity Care Programs 60750 1TransUnion Survey Finds Patients Want More Transparency in Hospital Bills and Knowledge of Charity Care Programs 60750 2TransUnion Survey Finds Patients Want More Transparency in Hospital Bills and Knowledge of Charity Care Programs 60750 3TransUnion Survey Finds Patients Want More Transparency in Hospital Bills and Knowledge of Charity Care Programs 60750 4Remote Heart Monitoring Platform Begins Validation 6004 1Remote Heart Monitoring Platform Begins Validation 6004 2Remote Heart Monitoring Platform Begins Validation 6004 3Remote Heart Monitoring Platform Begins Validation 6004 4BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 14731 1BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 14731 2BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 14731 3BioSoteria eLearning Executive Michelle Nolin Flewell Earns Certification 14731 4
...is available in German . , Halle/Saale. For the...ive overview of which alien species are present in...vironment and society. More than 11,000 alien spec...en Invasive Species Inventory for Europe), a uniqu...uropean scientists, funded by the European Union t...
... body,s immune system hates strangers. When its se... it. , This is the problem when people with type ...n. The islet cells from a donor pancreas produce r...n permitting independence from insulin therapy. Ho...d-working islets. , A person who has the transpla...
...al crime, treating an ageing population, and turni...he focus of a 20 million ($30.4 million) investmen...Sciences Research Council (EPSRC), Technology Stra...cal Sciences Research Council (BBSRC). , This new...here world-class scientific breakthroughs have alr...
Other Biology News:11,000 alien species invade Europe 2New technique eliminates toxic drugs in islet transplant in diabetic mice 2£20 million to fight virtual crime and treat our ageing population 2£20 million to fight virtual crime and treat our ageing population 3
...s designed for genome-wide microRNA expression pro...flo microfluidic on-chip synthesis platform. These...nsive microRNA Expression Profiling Service. Pro... all known maize microRNAs (43 unique mature seque...
...t 6850 Networked GC is an excellent choice for sup...int of a standard dual-channel GC, this one-channe...ng two GCs in the space of one. You get all the ca...nalyses in an instrument that has the same proven ...
...C system combines world-class performance hardware...software, Agilents world-renowned support and colu...pplies--a combination that lets you reach uncompro...based on dependable data. The Agilent 6820 GC syst...
... short years since publication of the best-selling...d Protein Protocols Handbook, there have been many...mistry. In recognition of the level of attention c... of new methodologies directed to study them, Dr. ...
Biology Products: